Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 4 , Pages 221-224 , August 2007

Efficacy of Family History in Determining Thrombophilia Risk

  • Jennifer E. Dietrich, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Jennifer E. Dietrich, MD, Department of Obstetrics, Gynecology and Women's Health, University of Louisville School of Medicine, 550 S. Jackson Street, Louisville, KY 40202
    • ,
  • S. Paige Hertweck, MD
    • ,
  • Sally E. Perlman, MD

References 

  1. Hormone Therapy ACOG Committee Opinion . Venous thromboembolic disease. Obstet Gynecol. 2004;104(Suppl):118S
  2. Murin S, Marelich GP, Arroliga AC, et al. Hereditary thrombophilia and venous thromboembolism. Amer J Resp Crit Care Med. 1998;158:1369
  3. Sass A, Neufield E. Risk factors for thromboembolism in teens: when should I test?. Cur Opin Pediatr. 2002;14:370
  4. vanOmmen C, Heijboer H, Buller HR. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001;139:676
  5. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian registry of VTE. Blood. 1994;83:1251
  6. Tabernero MD, Tomas JF, Alberca I, et al. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Amer J Hematol. 1991;36:249
  7. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Arterioscler Thromb Vasc Biol. 1996;16:742
  8. Junker R, Koch HG, Auberger K, et al. Prothrombin G20210A gene mutation and further prothrombin factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999;19:2568
  9. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Amer J Hematol. 2002;70(2):126
  10. Strater R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood—a 5-year follow-up study. Lancet. 2002;360(9345):1526
  11. Cattaneo M, Tsai MY, Bucciarelli P, et al. A common mutation on the methyltetrahydrofolate reductase gene (C677t) increases the risk for deep-venous thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol. 1997;17:1662
  12. Bauer K. Hypercoagulable states. Hematology. 2005;10(Suppl. 1):39

PII: S1083-3188(06)00341-X

doi: 10.1016/j.jpag.2006.11.008

Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 4 , Pages 221-224 , August 2007

Article Tools